Other Clinical Trial - Primary Immunodeficiency in Kuwait

Status Completed

Clinical Trial Summary

- Background/Rationale: Epidemiological data about Primary Immunodeficiency Disorders (PIDD) in Kuwait is needed to better understand peculiarities and to compare them with other regions and ethnicity.

- Study hypothesis: PIDD is relatively common in Kuwait compared to populations from different geographic areas. The distribution of PIDD in Kuwait is different from other geographic areas with more severe forms being more frequent.

- Brief inclusion and exclusion criteria of study participants: PIDD patients presented at different clinics/hospital in Kuwait. Patients with secondary immunodeficiencies (drug induced, virus induced, and immunodeficiency associated with metabolic disorders... ect), will be excluded

- Estimated sample size of the study: All patients who were registered in KNPIDR since 2004 will be included in the study along with the new patients who will be recruited during the study period.

- Primary objectives:

- Determine the prevalence and frequency of different PIDD in Kuwait

- Identify clinical presentation patterns for PIDD in Kuwait

- Identify natural history of PIDD in Kuwait

- Help to asses epidemiology of PIDD in Kuwait

- Determine particularities about PIDD affecting the population in Kuwait

- Determine the health impact of PIDD in Kuwait

- Development of strategies to improve the care and the quality of life of patients with PIDD

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Immunologic Deficiency Syndromes
Primary Immune Deficiency Disorder

Clinical Trial Details

NCT number	NCT03618147
Study type	Observational [Patient Registry]
Source	Kuwait Society for Allergy and Clinical Immunology
Contact
Status	Completed
Phase
Start date	July 16, 2018
Completion date	May 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03939533` - Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases	Phase 3
Recruiting	`NCT03266640` - Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)	Phase 2
Recruiting	`NCT03266627` - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection	Phase 2
Completed	`NCT01859754` - Octagam 5% Versus Comparator Post Marketing Trial
Recruiting	`NCT03148028` - Immunological Characteristics of Patients With PID and IBD	N/A
Active, not recruiting	`NCT04354818` - Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Completed	`NCT03988426` - Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases	Phase 3
Completed	`NCT01888484` - Study of Octanorm Subcutaneous IG in Patients With PID	Phase 3
Completed	`NCT01131858` - Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency	Phase 1/Phase 2
Completed	`NCT03211689` - The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease	N/A
Terminated	`NCT01883921` - Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Recruiting	`NCT03266653` - EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection	Phase 2
Completed	`NCT02327351` - TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID	Phase 2/Phase 3
Recruiting	`NCT04197596` - Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)	Phase 1/Phase 2
Recruiting	`NCT03422614` - Pathophysiology of Inborn Immunodeficiencies	N/A
Completed	`NCT02888535` - Intensive Care Unit and Secondary and Primary Immune Deficiency
Recruiting	`NCT04232085` - Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide	Phase 2
Active, not recruiting	`NCT03037359` - A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products
Completed	`NCT03069079` - Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study	N/A
Recruiting	`NCT03414528` - Identification of New Inborn Errors of Immunity	N/A